Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Intangibles: 2021-2025

Historic Intangibles for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Sep 2025 value amounting to $5.5 million.

  • Rhythm Pharmaceuticals' Intangibles fell 13.38% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 13.38%. This contributed to the annual value of $6.2 million for FY2024, which is 12.15% down from last year.
  • According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Intangibles is $5.5 million, which was down 3.72% from $5.7 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Intangibles registered a high of $8.5 million during Q1 2022, and its lowest value of $4.7 million during Q4 2021.
  • For the 3-year period, Rhythm Pharmaceuticals' Intangibles averaged around $6.6 million, with its median value being $6.6 million (2024).
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Intangibles skyrocketed by 70.54% in 2022, and later decreased by 13.38% in 2025.
  • Rhythm Pharmaceuticals' Intangibles (Quarterly) stood at $4.7 million in 2021, then spiked by 69.24% to $7.9 million in 2022, then decreased by 10.85% to $7.0 million in 2023, then dropped by 12.15% to $6.2 million in 2024, then declined by 13.38% to $5.5 million in 2025.
  • Its Intangibles stands at $5.5 million for Q3 2025, versus $5.7 million for Q2 2025 and $6.0 million for Q1 2025.